P. K. Somers

发表

EFFECTS OF AGI-1096, A NOVEL ANTIOXIDANT COMPOUND WITH ANTI-INFLAMMATORY AND ANTIPROLIFERATIVE PROPERTIES, ON RODENT ALLOGRAFT ARTERIOSCLEROSIS

R. Morris, R. Robbins, L. Balsam, 2004, Transplantation.

Novel phenolic antioxidants as multifunctional inhibitors of inducible VCAM-1 expression for use in atherosclerosis.

C. Kunsch, S. Parthasarathy, M. Wasserman, 2002, Bioorganic & medicinal chemistry letters.

Molecular Recognition of Immunophilins and Immunophilin-Ligand Complexes

S. Schreiber, T. Wandless, M. Albers, 1992 .

Synthesis of medium-sized ring ethers from thionolactones. Applications to polyether synthesis

K. Nicolaou, R. Hark, C. Prasad, 1990 .

Nucleophilic additions to thionolactones. New synthetic technology for the construction of medium and large ring ethers

K. Nicolaou, G. Furst, P. K. Somers, 1987 .

Total Synthesis of the Immunosuppressive Agent (‐)‐Discodermolide.

S. Schreiber, D. Hung, P. K. Somers, 1994 .

Dithiocarbamates: effects on lipid hydroperoxides and vascular inflammatory gene expression.

U. Saxena, R. Medford, P. K. Somers, 2000, Free radical biology & medicine.

Activation of 7-endo over 6-exo epoxide openings. Synthesis of oxepane and tetrahydropyran systems

K. Nicolaou, C. Prasad, C. Hwang, 1989 .

Activation of 6-endo over 5-exo hydroxy epoxide openings. Stereoselective and ring selective synthesis of tetrahydrofuran and tetrahydropyran systems

K. Nicolaou, C. Prasad, C. Hwang, 1989 .

Activation of 6-endo over 5-exo epoxide openings. Ring-selective formation of tetrahydropyran systems and stereocontrolled synthesis of the ABC ring framework of brevetoxin B

K. Nicolaou, M. Duggan, C. Hwang, 1985 .

Lead discovery of α,β-Unsaturated sulfones from a combinatorial library as inhibitors of inducible VCAM-1 expression

U. Saxena, K. Suen, C. Meng, 2003 .

Total Synthesis of Brevetoxin A: Part 1: First Generation Strategy and Construction of BCD Ring System

P. A. Wallace, M. Bunnage, K. Nicolaou, 1999 .

Total synthesis of the immunosuppressive agent (-)-discodermolide

S. Schreiber, D. Hung, P. K. Somers, 1993 .

Synthesis and analysis of 506BD, a high-affinity ligand for the immunophilin FKBP

S. Schreiber, T. Wandless, P. K. Somers, 1991 .

AGIX-4207 [2-[4-[[1-[[3,5-Bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic Acid], a Novel Antioxidant and Anti-Inflammatory Compound: Cellular and Biochemical Characterization of Antioxidant Activity and Inhibition of Redox-Sensitive Inflammat

A. Whalen, C. Kunsch, Xi-lin Chen, 2005, Journal of Pharmacology and Experimental Therapeutics.

AGI-1067: A Multifunctional Phenolic Antioxidant, Lipid Modulator, Anti-Inflammatory and Antiatherosclerotic Agent

R. Alexander, A. Daugherty, M. Wasserman, 2003, Journal of Pharmacology and Experimental Therapeutics.

Nitrobenzene compounds inhibit expression of VCAM-1.

U. Saxena, C. Meng, P. K. Somers, 2001, Bioorganic & medicinal chemistry letters.

Synthesis and Analysis of 506BD, a High‐Affinity Ligand for the Immunophilin FKBP.

S. Schreiber, T. Wandless, P. K. Somers, 1992 .

Discovery of novel phenolic antioxidants as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases.

C. Kunsch, M. Wasserman, U. Saxena, 2004, Journal of medicinal chemistry.